MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

No Stability Information

Bendroflumethiazide 5mg tablets (Bristol Laboratories Ltd)

Explore other Bendroflumethiazide formulations Explore other Bendroflumethiazide 5mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Bendroflumethiazide 5mg tablets (Crescent Pharma Ltd)

Explore other Bendroflumethiazide formulations Explore other Bendroflumethiazide 5mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Bendroflumethiazide 5mg tablets (Medihealth (Northern) Ltd)

Explore other Bendroflumethiazide formulations Explore other Bendroflumethiazide 5mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Bendroflumethiazide 5mg tablets (Phoenix Healthcare Distribution Ltd)

Explore other Bendroflumethiazide formulations Explore other Bendroflumethiazide 5mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Bendroflumethiazide 5mg tablets (Sigma Pharmaceuticals Plc)

Explore other Bendroflumethiazide formulations Explore other Bendroflumethiazide 5mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Benemid 500mg tablets (Imported (France))

Explore other Probenecid formulations Explore other Probenecid 500mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Benilexa One Handed 20micrograms/24hours intrauterine delivery system (Gedeon Richter (UK) Ltd)

Explore other Levonorgestrel formulations Explore other Levonorgestrel 20micrograms/24hours intrauterine device suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Benuryl 500mg tablets (Imported (Canada))

Explore other Probenecid formulations Explore other Probenecid 500mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Benzatropine 1mg tablets (Special Order)

Explore other Benzatropine formulations Explore other Benzatropine 1mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Benzatropine 2mg tablets (Special Order)

Explore other Benzatropine formulations Explore other Benzatropine 2mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Benzbromarone 100mg tablets (Special Order)

Explore other Benzbromarone formulations Explore other Benzbromarone 100mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Benzbromarone 50mg tablets (Special Order)

Explore other Benzbromarone formulations Explore other Benzbromarone 50mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Benznidazole 50mg tablets (Special Order)

Explore other Benznidazole formulations Explore other Benznidazole 50mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Benzyl benzoate 25% application (Drug Tariff Special Order)

Explore other Benzyl benzoate formulations Explore other Benzyl benzoate 25% application suppliers

Stability Notes

There are no stability notes available for this medicine.

Use with caution

Besavar XL 10mg tablets (Zentiva Pharma UK Ltd)

Explore other Alfuzosin formulations Explore other Alfuzosin 10mg modified-release tablets suppliers

Stability Notes

Slightly hygroscopic. Protect from light. Max 7 days in MCA.

Provenance

This compatibility recommendation is derived from Besavar XL 10mg tablets (Zentiva Pharma UK Ltd), Xatral XL 10mg tablets (Sanofi) and Vasran XL 10mg tablets (Ranbaxy (UK) Ltd).

Print this list

Compatible

Medicines suitable for use in MCAs, although use is likely to be off-label.  Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed).  Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices.  Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Use with caution

There are concerns about stability and/or there is a lack of stability data available. These medicines can theoretically be used in MCAs, although use is likely to be off-label.  Mitigation measures may need to be considered.  Keep medicines in MCAs for the shortest time necessary.  Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Incompatible

Medicines under this category are not suitable for use in MCAs.

No Stability Information

These medicines have not been reviewed by SPS.